EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors for Mortality Among Patients with Bloodstream Infection Caused by Candidozyma auris in Colombia

Mariana Pimiento-Díaz iD, Cynthia Ortiz-Roa, Sebastián Felipe Sierra-Umaña, José Yesid Rodríguez, Gerardo Antonio Muñetón-López, Carlos Augusto Solórzano-Ramos iD, Patricia Escandón iD, Carlos Arturo Álvarez-Moreno iD, Jorge Alberto Cortés iD

Antibiotics · 07.08.2026 · 15 (8) · 758

DOI: 10.3390/antibiotics15080758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 07.08.2026. Verfasst von Mariana Pimiento-Díaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Universidad Nacional de Colombia, Sede Bogotá 111321, Colombia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Candidozyma auris (Candida auris) is an emerging multidrug-resistant fungal pathogen that can cause hospital outbreaks and is associated with high mortality. However, data on the clinical predictors of mortality in patients with bloodstream infection (BSI) caused by C. auris remain limited, particularly in Latin America, and the impact of guideline-based management practices on clinical outcomes has been scarcely explored.

Methods

We conducted a multicenter retrospective cohort study including 134 patients with culture-proven C. auris BSI admitted to seven hospitals in Colombia between 2016 and 2021. Demographic, clinical, and therapeutic variables were evaluated to identify factors associated with 30-day mortality using a multivariate logistic regression model. Variables related to quality of care and guideline-based candidemia management, included in the EQUAL Candida Score, were also assessed.

Results

The thirty-day mortality rate was 38.1%. In the multivariate analysis, older age (OR per decade: 1.37; 95% CI: 1.07–1.78), prior corticosteroid therapy (OR: 4.06; 95% CI: 1.70–10.16), and shock within 48 h of BSI (OR: 6.22; 95% CI: 2.52–16.52) were associated with higher mortality. Conversely, a higher EQUAL Candida Score was associated with lower 30-day mortality (OR: 0.84; 95% CI: 0.73–0.97).

Conclusions

In this large Colombian cohort, advanced age, corticosteroid exposure, and early hemodynamic instability were significant predictors of mortality in patients with C. auris BSI. Greater adherence to recommended management practices—as reflected by the EQUAL Candida Score—appeared to be associated with lower mortality, underscoring the potential role of timely, structured care strategies in improving outcomes for patients with C. auris infections. To the best of our knowledge, this study is the first to evaluate the EQUAL Candida Score in a cohort of patients with C. auris BSI.

Schlagwörter

Stichwörter der Autor:innen

CandidaCandida aurisColombiacandidemiamortalityrisk factors

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Universidad Nacional de Colombia, Sede Bogotá 111321, Colombia.
  • Subred Integrada de Servicios de Salud Norte E.S.E. Hospital Simón Bolívar, Bogotá 111221, Colombia.
  • Subred Integrada de Servicios de Salud Sur E.S.E. Hospital Tunal, Bogotá 110621, Colombia.
  • Clínica Integral de Emergencias Laura Daniela, Facultad de Ciencias Médicas y de la Salud, Instituto Cardiovascular del Cesar, Centro de Investigaciones Microbiológicas del Cesar (CIMCE), Universidad de Santander, Valle…
  • Subred Integrada de Servicios de Salud Suroccidente E.S.E. Hospital de Kennedy, Bogotá 110871, Colombia.
  • Grupo de Microbiología, Instituto Nacional de Salud, Bogotá 111321, Colombia.

ORCID-Profile: Mariana Pimiento-Díaz, Carlos Augusto Solórzano-Ramos, Patricia Escandón, Carlos Arturo Álvarez-Moreno, Jorge Alberto Cortés

Zitieren

APA

Pimiento-Díaz, M., Ortiz-Roa, C., Sierra-Umaña, S. F., Rodríguez, J. Y., Muñetón-López, G. A., Solórzano-Ramos, C. A., Escandón, P., Álvarez-Moreno, C. A., & Cortés, J. A. (2026). Risk Factors for Mortality Among Patients with Bloodstream Infection Caused by Candidozyma auris in Colombia. Antibiotics, 15(8), 758. https://doi.org/10.3390/antibiotics15080758

Vancouver

Pimiento-Díaz M, Ortiz-Roa C, Sierra-Umaña SF, Rodríguez JY, Muñetón-López GA, Solórzano-Ramos CA, et al. Risk Factors for Mortality Among Patients with Bloodstream Infection Caused by Candidozyma auris in Colombia. Antibiotics. 2026;15(8):758. doi:10.3390/antibiotics15080758

BibTeX
@article{PimientoDaz2026,
  author = {Pimiento-Díaz, Mariana and Ortiz-Roa, Cynthia and Sierra-Umaña, Sebastián Felipe and Rodríguez, José Yesid and Muñetón-López, Gerardo Antonio and Solórzano-Ramos, Carlos Augusto and Escandón, Patricia and Álvarez-Moreno, Carlos Arturo and Cortés, Jorge Alberto},
  title = {Risk Factors for Mortality Among Patients with Bloodstream Infection Caused by Candidozyma auris in Colombia},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {758},
  doi = {10.3390/antibiotics15080758}
}
Kostenlos starten →